Cargando…
Prognostic impact of circulating tumor cells detected with the microfluidic “universal CTC‐chip” for primary lung cancer
Detecting rare circulating tumor cells (CTCs) in the bloodstream is extremely challenging. We had previously developed a novel polymeric microfluidic device, “CTC‐chip,” for capturing CTCs and have shown high capture efficiency in lung cancer cell lines by conjugating Abs against epithelial cell adh...
Autores principales: | Kanayama, Masatoshi, Kuwata, Taiji, Mori, Masataka, Nemoto, Yukiko, Nishizawa, Natsumasa, Oyama, Rintaro, Matsumiya, Hiroki, Taira, Akihiro, Shinohara, Shinji, Takenaka, Masaru, Yoneda, Kazue, Kuroda, Koji, Ohnaga, Takashi, Tanaka, Fumihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898730/ https://www.ncbi.nlm.nih.gov/pubmed/34964211 http://dx.doi.org/10.1111/cas.15255 |
Ejemplares similares
-
Prognostic impact of PD-L1 and TIGIT expression in non-small cell lung cancer following concurrent chemo-radiotherapy
por: Mori, Masataka, et al.
Publicado: (2023) -
Novel circulating tumor cell-detection chip combining conventional podoplanin and EGFR antibodies for all histological malignant pleural mesothelioma
por: Kanayama, Masatoshi, et al.
Publicado: (2021) -
CD155 expression and its clinical significance in non-small cell lung cancer
por: Oyama, Rintaro, et al.
Publicado: (2022) -
Detection of circulating tumor cells with a novel microfluidic system in malignant pleural mesothelioma
por: Yoneda, Kazue, et al.
Publicado: (2019) -
Detection of Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM) with the “Universal” CTC-Chip and An Anti-Podoplanin Antibody NZ-1.2
por: Kuwata, Taiji, et al.
Publicado: (2020)